ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 134 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2019. The put-call ratio across all filers is 3.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -25.0% | 530 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | -20.0% | 530 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | +25.0% | 530 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 530 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 530 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -33.3% | 530 | +28.6% | 0.00% | – |
| Q1 2022 | $6,000 | -50.0% | 412 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -25.0% | 412 | -14.5% | 0.00% | – |
| Q3 2021 | $16,000 | +45.5% | 482 | +74.6% | 0.00% | – |
| Q2 2021 | $11,000 | 0.0% | 276 | 0.0% | 0.00% | – |
| Q1 2021 | $11,000 | -26.7% | 276 | +7.4% | 0.00% | – |
| Q4 2020 | $15,000 | -57.1% | 257 | -64.5% | 0.00% | – |
| Q3 2020 | $35,000 | +75.0% | 723 | +3.0% | 0.00% | – |
| Q2 2020 | $20,000 | 0.0% | 702 | 0.0% | 0.00% | – |
| Q1 2020 | $20,000 | -4.8% | 702 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | – | 702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |